A Phase III randomised placebo-controlled trial of mirtazapine as a pharmacotherapy for methamphetamine ("Ice") dependence [ 2021-06-20T00:00:00 ]

Research Grant

Brief description Crystalline methamphetamine ('ice') is a growing concern in Australia. There are no approved medications that can be used to treat dependence on this drug. This clinical trial will examine whether mirtazapine, a newly identified treatment agent for methamphetamine use, can be used safely and effectively in routine clinical care to manage methamphetamine dependence in Australia.

Funding Amount $3,923,009.33

Funding Scheme Clinical Trials and Cohort Studies Grants

Chief Investigator A/Pr Rebecca McKetin

Notes Clinical Trials and Cohort Studies Grants